Factors Associated with Intention to Receive the TAK-003 Dengue Vaccine Among Adults in Endemic Regions of Peru: A Cross-Sectional Study

Background

Dengue vaccination is a promising preventive strategy. Peru introduced the TAK-003 vaccine in November 2024 for children aged 10-16 years and expanded it in January 2026 to individuals aged 10-20 years and selected priority adult groups. This study evaluated perceptions and intention to receive the dengue vaccine among adults before this expansion.